Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

Authoring Organization

Publication Month/Year

June 26, 2017

Last Updated Month/Year

April 13, 2023

Document Type


External Publication Status


Country of Publication


Document Objectives

To develop recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP).


Inclusion Criteria

Female, Male, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Hospital

Intended Users

Nurse, nurse practitioner, physician, physician assistant


Prevention, Treatment

Diseases/Conditions (MeSH)

D010024 - Osteoporosis, D005938 - Glucocorticoids


glucocorticoids, glucocorticoid‐induced osteoporosis, GIOP

Source Citation

Buckley, L., Guyatt, G., Fink, H.A., Cannon, M., Grossman, J., Hansen, K.E., Humphrey, M.B., Lane, N.E., Magrey, M., Miller, M., Morrison, L., Rao, M., Byun Robinson, A., Saha, S., Wolver, S., Bannuru, R.R., Vaysbrot, E., Osani, M., Turgunbaev, M., Miller, A.S. and McAlindon, T. (2017), 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. Arthritis Care & Research, 69: 1095-1110. doi:10.1002/acr.23279

Supplemental Methodology Resources

Data Supplement